Skip to main content

Table 1 Summary of stakeholder involvement

From: Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Stakeholders
Physicians (including dermatologists, plastic surgeons, international providers, physicians of other health care fields)
Patients
Nurses, physician assistants, or other health care providers
Industry scientists
Cosmetic groups/support groups
Pharmacologists/pharmacists
Drug and device safety regulators (e.g., FDA, EMA)
  1. EMA European Medicines Agency, FDA U.S. Food and Drug Administration